Trademarkia Logo

Canada

C$
NOVAVITA THERA
DEFAULT - SEARCHED

Last Applicant/ Owned by

Cytotheryx, Inc., a legal entity

c/o The Corporation Trust CompanyCorporation Trust Centre, 1209 Orange StreetWilmington, DE 19801

US

Serial Number

2101168 filed on 21st Apr 2021

Correspondent Address

RICHES, MCKENZIE & HERBERT LLP

SUITE 18002 BLOOR STREET EASTTORONTO

ONTARIO

CA

M4W3J5

NOVAVITA THERA

Trademark usage description

gene therapies, namely, in vivo and ex vivo vector treatments; lentiviral vector therapies; gene therapies for the treatment of rare diseases; gene th Read More

Classification Information


Class [003]
Gene therapies, namely, in vivo and ex vivo vector treatments; lentiviral vector therapies; gene therapies for the treatment of rare diseases; gene therapies for Hereditary Tyrosinemia Type 1; gene therapies for orphan disease; therapies for inborn errors of hepatic metabolism


Classification kind code

11

Class [005]
Pharmaceuticals and herbicides


Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details


Serial Number

2101168

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 14
on 20th May 2025
Default Notice Sent
Submitted for opposition 22
on 28th Oct 2024
Search Recorded
Submitted for opposition 20
on 28th Oct 2024
Examiner's First Report
Submitted for opposition 287
on 27th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 287
on 26th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 21st Apr 2021
Filed
Submitted for opposition 1
on 21st Apr 2021
Created
Submitted for opposition 31
on 21st Apr 2021
Formalized